NASDAQ:SRRK

Scholar Rock News Headlines

$27.81
-2.13 (-7.11 %)
(As of 04/12/2021 03:59 PM ET)
Add
Compare
Today's Range
$27.63
Now: $27.81
$29.54
50-Day Range
$31.80
MA: $53.43
$68.02
52-Week Range
$10.28
Now: $27.81
$70.00
Volume13,030 shs
Average Volume292,318 shs
Market Capitalization$952.85 million
P/E RatioN/A
Dividend YieldN/A
Beta0.35

Headlines

Scholar Rock (NASDAQ SRRK) News Headlines Today

SourceHeadline
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Scholar Rock Holding Corporation - SRRKSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Scholar Rock Holding Corporation - SRRK
finance.yahoo.com - April 12 at 12:18 PM
Scholar Rock Presents Biomarker Strategy to Support the SRK-181 DRAGON Phase 1 Proof-of-Concept Trial at the American Association for Cancer Research Annual MeetingScholar Rock Presents Biomarker Strategy to Support the SRK-181 DRAGON Phase 1 Proof-of-Concept Trial at the American Association for Cancer Research Annual Meeting
finance.yahoo.com - April 10 at 12:49 PM
Scholar Rock (NASDAQ:SRRK) Trading Down 4.4%Scholar Rock (NASDAQ:SRRK) Trading Down 4.4%
americanbankingnews.com - April 8 at 2:14 PM
Mid-Day Market Update: Crude Oil Rises Over 2%; Scholar Rock Shares PlungeMid-Day Market Update: Crude Oil Rises Over 2%; Scholar Rock Shares Plunge
markets.businessinsider.com - April 6 at 5:23 PM
Scholar Rock Holding is Now Oversold (SRRK)Scholar Rock Holding is Now Oversold (SRRK)
nasdaq.com - April 6 at 5:23 PM
Why Scholar Rock Shares Dropped Despite Positive Apitegromab Data In Spinal Muscular AtrophyWhy Scholar Rock Shares Dropped Despite Positive Apitegromab Data In Spinal Muscular Atrophy
finance.yahoo.com - April 6 at 5:23 PM
Scholar Rock Reports Apitegromab Data In Spinal Muscular AtrophyScholar Rock Reports Apitegromab Data In Spinal Muscular Atrophy
finance.yahoo.com - April 6 at 12:23 PM
Scholar Rock (NASDAQ:SRRK) Shares Gap Down to $45.13Scholar Rock (NASDAQ:SRRK) Shares Gap Down to $45.13
americanbankingnews.com - April 6 at 11:40 AM
Scholar Rock Announces Positive 12-Month Top-Line Results From the TOPAZ Phase 2 Clinical Trial Evaluating Apitegromab in Patients With Type 2 and Type 3 Spinal Muscular Atrophy (SMA)Scholar Rock Announces Positive 12-Month Top-Line Results From the TOPAZ Phase 2 Clinical Trial Evaluating Apitegromab in Patients With Type 2 and Type 3 Spinal Muscular Atrophy (SMA)
finance.yahoo.com - April 6 at 7:23 AM
Scholar Rock (NASDAQ:SRRK) Trading Down 4.8%Scholar Rock (NASDAQ:SRRK) Trading Down 4.8%
americanbankingnews.com - April 1 at 3:44 PM
Scholar Rock Announces Publication of Preclinical Pharmacology, Pharmacokinetics, and Safety Profile of SRK-181 in the International Journal of ToxicologyScholar Rock Announces Publication of Preclinical Pharmacology, Pharmacokinetics, and Safety Profile of SRK-181 in the International Journal of Toxicology
finance.yahoo.com - March 22 at 7:06 PM
Scholar Rock Holding Co. (NASDAQ:SRRK) Given Average Rating of "Buy" by BrokeragesScholar Rock Holding Co. (NASDAQ:SRRK) Given Average Rating of "Buy" by Brokerages
americanbankingnews.com - March 21 at 2:40 PM
Zacks: Brokerages Expect Scholar Rock Holding Co. (NASDAQ:SRRK) to Announce -$0.66 Earnings Per ShareZacks: Brokerages Expect Scholar Rock Holding Co. (NASDAQ:SRRK) to Announce -$0.66 Earnings Per Share
americanbankingnews.com - March 20 at 12:10 PM
Scholar Rock (NASDAQ:SRRK) Shares Gap Up to $60.72Scholar Rock (NASDAQ:SRRK) Shares Gap Up to $60.72
americanbankingnews.com - March 19 at 3:48 PM
Scholar Rock Announces the Addition of Joshua Reed to Its Board of DirectorsScholar Rock Announces the Addition of Joshua Reed to Its Board of Directors
finance.yahoo.com - March 19 at 9:51 AM
Scholar Rock Announces Issuance of U.S. Patent Protecting Add-On or Combination Therapy with a Myostatin Inhibitor for the Treatment of Spinal Muscular AtrophyScholar Rock Announces Issuance of U.S. Patent Protecting Add-On or Combination Therapy with a Myostatin Inhibitor for the Treatment of Spinal Muscular Atrophy
finance.yahoo.com - March 17 at 7:01 PM
Scholar Rock Presents TOPAZ Interim Analysis Data for Apitegromab in Spinal Muscular Atrophy at the 2021 Muscular Dystrophy Association (MDA) Virtual Clinical & Scientific ConferenceScholar Rock Presents TOPAZ Interim Analysis Data for Apitegromab in Spinal Muscular Atrophy at the 2021 Muscular Dystrophy Association (MDA) Virtual Clinical & Scientific Conference
finance.yahoo.com - March 15 at 9:33 AM
Scholar Rock Holding Corporation (SRRK) Reports Q4 Loss, Misses Revenue EstimatesScholar Rock Holding Corporation (SRRK) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - March 9 at 10:34 PM
Scholar Rock Reports Full Year 2020 Financial Results and Highlights Business ProgressScholar Rock Reports Full Year 2020 Financial Results and Highlights Business Progress
finance.yahoo.com - March 9 at 5:30 PM
Analysts Estimate Scholar Rock Holding Corporation (SRRK) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Scholar Rock Holding Corporation (SRRK) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - March 4 at 2:30 PM
Scholar Rock Announces Senior Management PromotionsScholar Rock Announces Senior Management Promotions
finance.yahoo.com - February 4 at 8:05 PM
Scholar Rock Presents Preclinical Data for SRK-181 at the TGFβ for Immuno-Oncology Drug Development SummitScholar Rock Presents Preclinical Data for SRK-181 at the TGFβ for Immuno-Oncology Drug Development Summit
finance.yahoo.com - January 27 at 12:08 PM
Scholar Rock Provides Corporate Update and Highlights Priorities for 2021Scholar Rock Provides Corporate Update and Highlights Priorities for 2021
finance.yahoo.com - January 11 at 9:30 AM
Scholar Rock to Present at the 39th Annual J.P. Morgan Healthcare ConferenceScholar Rock to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 6:01 PM
Nio, Snap Show Rare Chart Pattern, But Are They Buys?Nio, Snap Show Rare Chart Pattern, But Are They Buys?
finance.yahoo.com - December 11 at 3:23 AM
Do Hedge Funds Love Scholar Rock Holding Corporation (SRRK)?Do Hedge Funds Love Scholar Rock Holding Corporation (SRRK)?
finance.yahoo.com - November 29 at 4:10 PM
Scholar Rock Holding CorporationScholar Rock Holding Corporation
benzinga.com - November 26 at 11:58 PM
News for Scholar Rock Holding Corporation Registered shsNews for Scholar Rock Holding Corporation Registered shs
markets.businessinsider.com - November 17 at 6:58 PM
Earnings Update: Scholar Rock Holding Corporation (NASDAQ:SRRK) Just Reported And Analysts Are Boosting Their EstimatesEarnings Update: Scholar Rock Holding Corporation (NASDAQ:SRRK) Just Reported And Analysts Are Boosting Their Estimates
finance.yahoo.com - November 13 at 12:21 PM
What Percentage Of Scholar Rock Holding Corporation (NASDAQ:SRRK) Shares Do Insiders Own?What Percentage Of Scholar Rock Holding Corporation (NASDAQ:SRRK) Shares Do Insiders Own?
finance.yahoo.com - November 9 at 5:56 PM
Scholar Rock Reports Third Quarter 2020 Financial Results and Highlights Business ProgressScholar Rock Reports Third Quarter 2020 Financial Results and Highlights Business Progress
finance.yahoo.com - November 9 at 12:50 PM
Scholar Rock Is At Phase 2, $1 Billion Is Too ExpensiveScholar Rock Is At Phase 2, $1 Billion Is Too Expensive
seekingalpha.com - November 4 at 12:55 PM
2 Top Biotech Stocks From the IPO Class of 2018 to Buy Now2 Top Biotech Stocks From the IPO Class of 2018 to Buy Now
finance.yahoo.com - November 4 at 7:55 AM
Scholar Rock Announces Closing of Public Offering of Common Stock and Prefunded Warrants and Full Exercise of Underwriters Option to Purchase Additional SharesScholar Rock Announces Closing of Public Offering of Common Stock and Prefunded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - November 2 at 6:16 PM
Scholar Rock prices ~$200M equity offering.Scholar Rock prices ~$200M equity offering.
seekingalpha.com - October 29 at 10:48 AM
Stock Alert: Scholar Rock Holding Corporation Uptick ContinuesStock Alert: Scholar Rock Holding Corporation Uptick Continues
nasdaq.com - October 28 at 12:35 PM
Biotech Stock Roundup: GILD's Veklury Approved, NVAX Provides Vaccine Update & MoreBiotech Stock Roundup: GILD's Veklury Approved, NVAX Provides Vaccine Update & More
finance.yahoo.com - October 28 at 12:35 PM
Scholar Rock under pressure on proposed public offeringScholar Rock under pressure on proposed public offering
seekingalpha.com - October 27 at 7:53 PM
Scholar Rock Shines On TOPAZ Data, Stock Hits New HighScholar Rock Shines On TOPAZ Data, Stock Hits New High
nasdaq.com - October 27 at 2:53 PM
Stock Alert: Scholar Rock Soars 45% On Positive Data From Spinal Muscular Atrophy Treatment TrialStock Alert: Scholar Rock Soars 45% On Positive Data From Spinal Muscular Atrophy Treatment Trial
nasdaq.com - October 27 at 2:53 PM
Why Scholar Rock Stock Is Skyrocketing TodayWhy Scholar Rock Stock Is Skyrocketing Today
finance.yahoo.com - October 27 at 2:53 PM
Scholar Rocks SRK-015 shows positive effect in mid-stage spinal muscular atrophy studyScholar Rock's SRK-015 shows positive effect in mid-stage spinal muscular atrophy study
seekingalpha.com - October 27 at 9:52 AM
Scholar Rock Announces Positive Proof-of-Concept Data from TOPAZ Phase 2 Trial Interim Analysis of SRK-015 in Patients with Type 2 and Type 3 Spinal Muscular AtrophyScholar Rock Announces Positive Proof-of-Concept Data from TOPAZ Phase 2 Trial Interim Analysis of SRK-015 in Patients with Type 2 and Type 3 Spinal Muscular Atrophy
finance.yahoo.com - October 27 at 9:52 AM
Scholar Rock secures $50M debt facility for advancing pipelineScholar Rock secures $50M debt facility for advancing pipeline
seekingalpha.com - October 19 at 8:49 AM
Scholar Rock (SRRK) Presents At Morgan Stanley 18th Annual Global Healthcare Conference - SlideshowScholar Rock (SRRK) Presents At Morgan Stanley 18th Annual Global Healthcare Conference - Slideshow
seekingalpha.com - September 17 at 8:12 PM
Dosing is underway in early-stage study for Scholar Rocks SRK-181 in solid tumorsDosing is underway in early-stage study for Scholar Rock's SRK-181 in solid tumors
seekingalpha.com - September 9 at 10:04 AM
Scholar Rock Announces First Patient Dosed in Part A2 of DRAGON Phase 1 Proof-of-Concept Trial of SRK-181 to Overcome Primary Resistance to Anti-PD-(L)1 TherapyScholar Rock Announces First Patient Dosed in Part A2 of DRAGON Phase 1 Proof-of-Concept Trial of SRK-181 to Overcome Primary Resistance to Anti-PD-(L)1 Therapy
finance.yahoo.com - September 9 at 10:04 AM
Heres Why Were Not At All Concerned With Scholar Rock Holdings (NASDAQ:SRRK) Cash Burn SituationHere's Why We're Not At All Concerned With Scholar Rock Holding's (NASDAQ:SRRK) Cash Burn Situation
finance.yahoo.com - September 4 at 8:18 PM
Here's Why We're Not At All Concerned With Scholar Rock Holding's (NASDAQ:SRRK) Cash Burn SituationHere's Why We're Not At All Concerned With Scholar Rock Holding's (NASDAQ:SRRK) Cash Burn Situation
finance.yahoo.com - September 4 at 8:18 PM
Will TOPAZ Add Sheen To Scholar Rock?Will TOPAZ Add Sheen To Scholar Rock?
nasdaq.com - August 27 at 9:00 AM
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.